Last reviewed · How we verify
NCT03868696: UDiReCT
Ultrasound Directed Reduction of Colles Type Distal Radial Fractures in ED (UDiReCT)
NA trial testing MUA with sham ultrasound in Radius Distal Fracture in 48 participants. Completed in 6 July 2020.
6 April 2020
Quick facts
| Lead sponsor | Royal Devon and Exeter NHS Foundation Trust |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 48 |
| Start date | 7 October 2019 |
| Primary completion | 6 April 2020 |
| Estimated completion | 6 July 2020 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- MUA with sham ultrasound
- MUA with active ultrasound
Conditions studied
- Radius Distal Fracture — all drugs for Radius Distal Fracture →
- Colles' Fracture — all drugs for Colles' Fracture →
Sponsor
Royal Devon and Exeter NHS Foundation Trust
Who can join
18 and older, any sex, with Radius Distal Fracture or Colles' Fracture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a limited two centre randomized controlled feasibility trial towards a larger definitive trial designed to assess whether bed side ultrasound can reduce the rate of surgical fixation following emergency department manipulation of Colles' type wrist fractures. UDiReCT will mirror the proposed design of the definitive trial but will report feasibility data such as recruitment rate, data completeness and reliability of potential definitive trial outcome measures.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Ultrasound Directed Reduction of Colles' type distal radial fractures in ED (UDiReCT): a feasibility randomised controlled trial.
Malik H, Wood D, Stone O, Gough A, et al · · 2023 · cited 1× · PMID 37890981 · DOI 10.1136/emermed-2023-213279
Verify or expand the search:
- PubMed search for NCT03868696
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Royal Devon and Exeter NHS Foundation Trust trials
Trials by the same sponsor.
- NCT06685874 — Interstitial Lung Disease Exacerbations Study · active not recruiting
- NCT06903780 — Experience of Biologic Treatments for Severe Asthma: a Survey · recruiting
- NCT06798779 — Predicting Manifest Astigmatism in Keratoconus Patients. · active not recruiting
- NCT06523452 — Laser Speckle Imaging During Breast Reconstruction · NA · recruiting
- NCT06099691 — Outcomes That Matter and Questionnaires for Older People With Frailty · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03868696 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Royal Devon and Exeter NHS Foundation Trust
- Last refreshed: 12 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03868696.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing